Found: 35
Select item for more details and to access through your institution.
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
HERe-2 stay: the continuing importance of translational research in breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Wnt signaling in triple negative breast cancer is associated with metastasis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Twenty Years of Systemic Therapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1833
- By:
- Publication type:
- Article
Twenty Years of Systemic Therapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 1, p. 25
- By:
- Publication type:
- Article
Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1995, v. 87, n. 20, p. 1546, doi. 10.1093/jnci/87.20.1546
- By:
- Publication type:
- Article
HER2011: The Changing Face of HER2-Positive Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 1, p. 9, doi. 10.3816/CBC.2011.n.001
- By:
- Publication type:
- Article
Selected Phase III Trials in Recurrent/Metastatic Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 492, doi. 10.1016/S1526-8209(11)70200-2
- By:
- Publication type:
- Article
Selected Neoadjuvant and Adjuvant Trials in Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 5, p. 407, doi. 10.1016/S1526-8209(11)70060-X
- By:
- Publication type:
- Article
Selected Phase III Trials in Recurrent/Metastatic Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 326, doi. 10.1016/S1526-8209(11)70047-7
- By:
- Publication type:
- Article
Ten Remarkable Years.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 3, p. 178, doi. 10.3816/CBC.2010.n.024
- By:
- Publication type:
- Article
Selected Neoadjuvant and Adjuvant Trials in Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 3, p. 246, doi. 10.1016/S1526-8209(11)70035-0
- By:
- Publication type:
- Article
Selected Phase III Trials in Recurrent/Metastatic Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 164, doi. 10.1016/S1526-8209(11)70025-8
- By:
- Publication type:
- Article
Where to With HER2?
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 1, p. 18, doi. 10.3816/CBC.2010.n.001
- By:
- Publication type:
- Article
Screening for Breast Cancer: Is the Picture Changing?
- Published in:
- Clinical Breast Cancer, 2009, v. 9, n. 4, p. 212, doi. 10.3816/CBC.2009.n.035
- By:
- Publication type:
- Article
What's PARPing Up for Triple-Negative Breast Cancer?
- Published in:
- Clinical Breast Cancer, 2009, v. 9, n. 3, p. 139, doi. 10.3816/CBC.2009.n.022
- By:
- Publication type:
- Article
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 1, p. 171, doi. 10.1007/s10549-022-06611-6
- By:
- Publication type:
- Article
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1235902
- By:
- Publication type:
- Article
Integrated digital error suppression for improved detection of circulating tumor DNA.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 547, doi. 10.1038/nbt.3520
- By:
- Publication type:
- Article
Molecular Analysis of Thymoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042669
- By:
- Publication type:
- Article
TCGA's Breast Cancer Project May Yield Important Therapeutic Benefits, but It's Too Early to Be Sure.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 12, p. 1280
- By:
- Publication type:
- Article
The New Millennium for Adjuvant Therapy in Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 6, p. 598
- By:
- Publication type:
- Article
Is HER-2/neu a Predictor of Anthracycline Utility? No.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 30, p. 85
- By:
- Publication type:
- Article
The Optimal Duration of Endocrine Therapy in Hormone Receptor-Positive Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 6, p. 383
- By:
- Publication type:
- Article
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 2, p. 751, doi. 10.1007/s10549-012-2112-7
- By:
- Publication type:
- Article
Synergistic drug combinations from electronic health records and gene expression.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Repression of GADD153/CHOP by NF-κB: a possible cellular defense against endoplasmic reticulum stress-induced cell death.
- Published in:
- Oncogene, 2001, v. 20, n. 17, p. 2178, doi. 10.1038/sj.onc.1204292
- By:
- Publication type:
- Article
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 8, p. 1328, doi. 10.1038/s41416-024-02826-0
- By:
- Publication type:
- Article
Altered expression of telomere‐associated genes in leukocytes among BRCA1 and BRCA2 carriers.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 4, p. 567, doi. 10.1002/mc.22773
- By:
- Publication type:
- Article
Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02530
- By:
- Publication type:
- Article
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 10, p. 701, doi. 10.1093/jnci/djt067
- By:
- Publication type:
- Article
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1038, doi. 10.1007/s12282-021-01239-8
- By:
- Publication type:
- Article
Wnt signaling in triple negative breast cancer is associated with metastasis.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-537
- By:
- Publication type:
- Article